Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
Sponsor and Collaborators
Medical University of South Carolina
Alan Brisendine, CCRP
Melanie B. Thomas, MD Medical University of South Carolina
Next post in Liver Cancer Clinical Trials
Want to view more content from Cancer Therapy Advisor?
Register now at no charge to access unlimited clinical news, full-length features, case studies, conference coverage, and more.
Want to read more?
Please login or register first to view this content.